Social Security Announces Major Change
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
The Social Security Administration announced that it has added 13 conditions to its Compassionate Allowances (CAL) list on Monday.
The added conditions aim to accelerate disability determinations for people with serious medical conditions, the agency said in a press release.
Why It Matters
The CAL initiative was designed to fast-track claims for applicants whose diagnoses clearly met Social Security's statutory standard for disability.
More than 1.1 million applicants have been approved through the accelerated pathway since CAL began, according to the SSA press release.
What To Know
The expansion increased the total number of conditions on the CAL list to 300, which the SSA said would help the agency reach decisions more quickly for applicants with specific, severe diseases and conditions.
The 13 conditions added in the Monday announcement include:
Au-Kline Syndrome
Bilateral Anophthalmia
Carey-Fineman-Ziter Syndrome
Harlequin Ichthyosis – Child
Hematopoietic Stem Cell Transplantation
LMNA-related Congenital Muscular Dystrophy
Progressive Muscular Atrophy
Pulmonary Amyloidosis – AL Type
Rasmussen Encephalitis
Thymic Carcinoma
Turnpenny-Fry Syndrome
WHO Grade III Meningiomas
Zhu-Tokita-Takenouchi-Kim Syndrome
According to the SSA, when applicants submit medical evidence indicating a CAL condition, the agency can identify and prioritize those claims using advanced tools.
The CAL list was first introduced to reduce waiting times for applicants with clearly disabling conditions, and the SSA said the program remains fully policy-compliant while speeding determinations for eligible claimants.
File photo of a Social Security Administration office in Washington, D.C.
File photo of a Social Security Administration office in Washington, D.C.
SAUL LOEB/AFP via Getty Images
What People Are Saying
SSA Commissioner Frank Bisignano, in a statement: "We are constantly looking for ways to improve our disability programs and serve the public more effectively. By adding these 13 conditions to the Compassionate Allowances list, we are helping more people with devastating diagnoses to quickly receive the support they need. This is part of our broader commitment to making the disability determination process as responsive and compassionate as possible."
Alex Beene, a financial literacy instructor for the University of Tennessee at Martin, told Newsweek: "This is certainly welcome news for Americans who have any of the 13 added conditions to the list of those that now qualify for expedited consideration under the Compassionate Allowances List the administration provides. For some disability benefits under SSA, wait times can be lengthy in order for the administration to verify the potential beneficiary's condition and determine the next steps."
Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek: "While claims still have to go through the traditional process, the agency is now using advanced technology to speed things up. If you're diagnosed with something on the Compassionate Allowances list, your claim could be processed much faster."
What Happens Next
The SSA encourages applicants to apply online at SSA.gov if they believe they have a CAL condition.
"Long term, this could mean fewer delays and less financial strain for those facing serious medical conditions, but it also puts pressure on Social Security to keep up with technology and ensure the system remains fair and accurate," Thompson said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
an hour ago
- Newsweek
Sleepless Nights? Your Gut Might Be To Blame
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Gut health can impact everything from mental health to the immune system—and it could be behind poor sleep too. Specific types of gut bacteria have now been linked to insomnia risk by researchers from The Affiliated Brain Hospital of Nanjing Medical University in China. The team found that certain types of bacteria seem to boost or lower the risk of the sleep condition, while insomnia itself may in turn also alter the abundance of certain gut 'bugs'. It is estimated that 12 percent of people in the U.S. have been diagnosed with chronic insomnia, according to the American Academy of Sleep Medicine. Insomnia involves difficulty falling asleep, waking up during the night, lying awake at night and waking up too early—all of which come with daytime symptoms of tiredness and irritability too. Man sitting on the edge of his bed with his hand's in his hands in the middle of the night. Man sitting on the edge of his bed with his hand's in his hands in the middle of the night. Visions/Getty Images While previous studies have explored the effects of the gut microbiome on various sleep characteristics, it is not clear how different groups of gut bacteria might affect the risk of insomnia. The researchers explored data on 386,533 people with insomnia from a previously published genome-wide analysis study, gut microbiome data for 18,340 people from the MiBioGen alliance and for 8,208 people from the Dutch Microbiome Project with (71 groups of bacteria in common). Their analysis revealed associations between specific gut microbes and insomnia. Overall, a total of 14 groups of bacteria were positively associated with insomnia (1–4 percent higher odds) and eight groups showed a negative association (1–3 percent lower odds.) Insomnia itself was associated with a reduction of between 43 percent and 79 percent in the abundance of seven groups of bacteria and a 65 percent to a more than fourfold increase in the abundance of 12 other groups. The Odoribacter class of bacteria, in particular, was significantly associated with the risk of insomnia, the team reported. "Odoribacter plays a role in producing short-chain fatty acids like butyrate, which influence inflammation, neurotransmitter balance and circadian regulation," gastroenterologist Lindsey Ann Edwards of King's College London—who was not involved in the present study—told Newsweek. "Interestingly, its effects aren't universally 'good' or 'bad'—it has been shown to have positive or negative impacts depending on the disease in question. Its influence also depends heavily on an individual's overall microbiome composition, because gut bacteria interact as a community. "Through a process called metabolic cross-feeding, one species' waste products can serve as another's fuel, meaning the broader microbial network often determines whether Odoribacter's presence is helpful or harmful." 3D illustration of human intestine and microbiome. 3D illustration of human intestine and researchers note that no pleiotropy—the production by a single gene of two or more apparently unrelated effects—was identified, strengthening the integrity of the findings and implying causation. "It's a fascinating and promising line of research. The link between gut microbiota and sleep is still emerging, and this study adds another important piece to the puzzle," Edwards said. "While it's still early days, the fact that they've identified potential causal relationships makes the findings especially interesting. That said, the results need to be interpreted with caution until confirmed by larger, randomized controlled trials." The study authors said limitations include all participants being of European descent (and the makeup of the microbiome varying among different ethnicities and geographies). Factors like diet and lifestyle, known to affect the microbiome and the interplay between genes and the environment, also weren't accounted for. Edwards explained that while bacteria are linked to insomnia, those same bacteria may themselves be shaped by a person's eating habits, stress levels, and environment. "Diet is one of the strongest influences we know of; for example, the types of fibre and plant diversity in the diet can shift bacterial populations sometimes even within days," Dr. Emily Prpa—a registered nutritionist at Yakult who was also not involved in the study—told Newsweek. "Lifestyle factors such as exercise and alcohol intake also play a role, as do environmental exposures like pollution, medications, social life and geography. Genetics influences the microbiome too, though to a smaller degree than lifestyle. One big omission in this study is stress—it's both a known disruptor of sleep and a factor that can significantly alter the gut microbiome via the gut–brain axis." The researchers concluded that the intertwined effects of insomnia on gut microbiota, and vice versa, represent a complex relationship involving immune regulation, inflammatory response and the release of neurotransmitters, as well as other molecular and cellular pathways. "Our study offers preliminary evidence supporting a causal effect between insomnia and gut microbiota, providing valuable insights for the future development of microbiome-inspired treatment plans for insomnia," the researchers explained in a statement. These could include the use of probiotics, prebiotics, or fecal microbiota transplantation (FMT, transferring healthy gut bacteria via a donor's stool), they said. "In theory—probiotics, prebiotics or FMT could introduce or encourage beneficial bacteria. However, gut ecosystems are complex," Edwards emphasized. "Simply adding 'good' bacteria doesn't guarantee they'll establish themselves or outcompete the 'bad' ones, especially if the underlying causes (like poor diet or chronic stress) remain. Success would likely require a combination of targeted bacteria plus supportive diet and lifestyle changes." Edwards said the next step in this field of research should be well-designed randomized controlled trials to confirm whether modifying gut bacteria can directly improve insomnia symptoms. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about gut health and sleep? Let us know via health@ Reference Jansen, P. R., Watanabe, K., Stringer, S., Skene, N., Bryois, J., Hammerschlag, A. R., de Leeuw, C. A., Benjamins, J. S., Muñoz-Manchado, A. B., Nagel, M., Savage, J. E., Tiemeier, H., White, T., Tung, J. Y., Hinds, D. A., Vacic, V., Wang, X., Sullivan, P. F., van der Sluis, S., ... Posthuma, D. (2019). Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nature Genetics, 51(3), 394–403. Shi, S., Liu, D., Baranova, A., Cao, H., & Zhang, F. (2025). Investigating bidirectional causal relationships between gut microbiota and insomnia. General Psychiatry, 38, e101855.
Epoch Times
6 hours ago
- Epoch Times
Social Security Updates 13 New Medical Conditions for Faster Benefits Processing
The Social Security Administration (SSA) has updated its Compassionate Allowances (CAL) list of severe disabilities to include 13 new medical conditions, allowing people with these illnesses to secure disability benefits faster, the agency said in an Aug. 11 statement. When an applicant's condition is mentioned on the list, SSA flags the application to expedite the review process. In certain cases, medical records may be obtained electronically, cutting down processing times even further.
Newsweek
7 hours ago
- Newsweek
Common Food Bacteria 'Could Transform Nutrition and Medicine'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Common food bacteria could be rewired to produce more vitamins—and "help to transform nutrition and medicine." This is the discovery of scientists at Rice University who have revealed how a bacterium called Lactococcus lactis regulates the production of a key precursor in the production of vitamin K₂, which is important for bone health, vascular health and clotting factors that stop bleeding. The bacteria create enough of this precursor to support their growth while preventing toxic buildup. "Vitamin-producing microbes could transform nutrition and medicine, but we must first decode their inherent checks and balances," said paper author and biosciences researcher professor Caroline Ajo‑Franklin in a statement. "Our work shows how L. lactis finely tunes its internal supply of the K₂ precursor, allowing us to rewire it with precision." The method could improve supplements and fortified foods and make vitamins cheaper and more environmentally friendly. Digital 3D illustration of probiotic bacteria. Digital 3D illustration of probiotic microbes to overproduce vitamins provides a greener and more cost-effective alternative to chemical synthesis or extraction from plants and animals, the researchers said. However, bacterial cells typically limit their production to self-sustaining levels. By dissecting the control system for the vitamin K₂ (also known as menaquinone) precursor, the study authors have identified how "substrate availability" and "genetic architecture" impose a production ceiling and how those limits can be lifted. The study focuses on the "unstable intermediate compound" that channels all forms of vitamin K₂. "A vitamin K₂ deficiency usually manifests as a propensity for excess bleeding, bruising and potentially gastrointestinal bleeding," Ajo‑Franklin told Newsweek. "It can be particularly hazardous for newborns, who can experience intracranial bleeding. As a result, it is standard care in the United States for all babies to receive a vitamin K₂ shot at birth. "A vitamin K deficiency can be caused by insufficient consumption of fermented food (natto, sauerkraut, cheeses, etc.) and animal products like egg yolks, fatty fish, or diseases/conditions that impair the body's ability to absorb vitamin K₂ in the gut, like celiac disease, cystic fibrosis or extended use of antibiotics. She added: "Vegan diets can be low in K₂ unless supplemented." Closed up shot of woman's hand taking supplement capsule. Closed up shot of woman's hand taking supplement researchers used a three-prong approach in their investigation, including biosensing (a device that can detect biological substances), genetic engineering and mathematical modeling. They built a custom biosensor in a different bacterium to help detect the precursor—thousands of times more sensitive than conventional methods and requiring minimal lab equipment. Next, they used the genetic tools to alter the levels of enzymes in the biosynthetic pathway. By measuring precursor output under different conditions, they fed the results into a mathematical model of the pathway. At first, the model assumed an unlimited precursor supply, but predictions didn't align with laboratory results. "Once we allowed for depletion of the starting substrate, the model output matched our experimental data," said paper author and computational systems biologist Oleg Igoshin, study author in a statement. "It became clear that cells hit a natural production ceiling when the substrate runs low." Just overexpressing pathway enzymes did not increase output beyond the threshold, however, because precursor materials became limited. The researchers compared this to attempting to bake more cookies with extra baking sheets, but without enough flour. However, the order of enzyme-encoding genes on DNA also influenced precursor levels. They found rearranging these genes altered how much intermediate the cell produced, suggesting an additional layer of "evolutionary regulation" that has not been well understood. "By tuning substrate supply, enzyme expression and gene order simultaneously, we can push production above the natural ceiling," said paper author and biochemist Siliang Li, in a statement. This opens the door to engineering L. lactis or other food-grade bacteria to produce more vitamin K₂ in fermentation processes in probiotic formulations, the researchers said. L. lactis, Ajo‑Franklin explained, "is also a probiotic bacterium, meaning that it promotes a healthy gut. It is found in a variety of fermented foods, most notably cheese and yogurt." "We've figured out how to reprogram the cells to make more vitamin K₂ with the natural enzymes they produce. We discovered the cells are very carefully controlling the production of vitamin K₂ through two overlapping control mechanisms. With this understanding, we can now predict what changes we need to make to override that control. "Previous efforts were only partially successful because they didn't know about both control points." Ajo‑Franklin added that it could lower the cost of current vitamin K₂ production. "Additionally, being able to produce vitamin K₂ by bacteria allows you to make it wherever needed, whether that's in space or somewhere on Earth, far away from large manufacturing facilities." If vitamin K₂ is produced by bacteria in the gut, the researchers said there is a possibility of the absorption being more effective than standard vitamin tablets. With Vitamin C and vitamin B₁₂ both currently manufactured using microorganisms, the researchers said a similar approach might enable them to make higher levels of these vitamins too. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about vitamins? Let us know via health@ Reference Li, S., Zhang, J., Ajo-Franklin, C. M., & Igoshin, O. A. (2025). The growth benefits and toxicity of quinone biosynthesis are balanced by a dual regulatory mechanism and substrate limitations. mBio.
